Notably, the FEO-CSNPs significantly downregulated key oncogenes such as PIK3CA, CCDN1, HER2, and WNT1, while upregulating the tumor suppressors TP53 and CDH1, indicating their potent anti-cancer activity. Here, ERBB2 is linked to cancer.